Physician profile
Sean P Mazer
NPI 1821025545
$274,231.26
in general payments reported to CMS, 2019-2025
32 companies · $34K in 2025
The $34K reported for 2025 was more than what 93% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128K · 2020: $22K · 2021: $12K · 2022: $30K · 2023: $18K · 2024: $30K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Food and Beverage: $7,021 · Travel and Lodging: $4,331 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,837.50 |
| Food and Beverage | $7,021.18 |
| Travel and Lodging | $4,330.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $134,107.08 | 2019-2024 | Carto 3 |
| Biosense Webster, INC. | $72,507.99 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Medtronic Vascular, INC. | $41,394.88 | 2019-2020 | |
| Abbott Laboratories | $11,606.27 | 2019-2023 | Allure, Aveir, Assurity |
| Boston Scientific Corporation | $6,323.12 | 2019-2025 | Watchman Access System, Watchman Flx, Watchman |
| Medtronic, INC. | $4,695.34 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Affera Mapping System |
| Abiomed | $762.40 | 2019-2025 | Impella |
| Stereotaxis INC | $547.07 | 2021-2024 | Genesis |
| Amgen INC. | $336.97 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $319.90 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $258.80 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $209.35 | 2019-2025 | Camzyos, Eliquis |
| Atricure, INC. | $200.15 | 2022-2025 | Lariat Rs |
| Philips North America LLC | $143.65 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.65 | 2019-2025 | Lifevest |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $121.55 | 2019-2023 | Farxiga |
| Zoll Respicardia, INC. | $67.69 | 2025 | Remede System |
| Baxter Healthcare | $65.18 | 2025 | Hillrom - Carnation Ambulatory Monitor, Perclot |
| Edwards Lifesciences Corporation | $48.28 | 2022 | |
| W. L. Gore & Associates, INC. | $46.58 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $45.92 | 2024-2025 | Verquvo |
| Pfizer INC. | $44.13 | 2019-2022 | |
| Shockwave Medical, INC | $43.95 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inspire Medical Systems, INC. | $41.18 | 2023 | Inspire |
| Itamar Medical INC | $40.98 | 2022-2024 | Watchpatone |
| Terumo Medical Corporation | $20.04 | 2024 | Optitorque |
| Sanofi-Aventis U.S. LLC | $18.22 | 2019 | |
| Chiesi USA, INC. | $15.88 | 2024 | Cleviprex, Kengreal |
| Angiodynamics, INC. | $14.60 | 2024 | Angiovac |
| Cardiva Medical, INC. | $13.86 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bayer Healthcare Pharmaceuticals INC. | $13.84 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Mazer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.